Olon Expands Pipeline With Pralsetinib And Trilaciclib

Announces Two ‘NIBs’ With Proprietary Technology And Patent Filings

 
• By Dave Wallace

API specialist Olon has announced the expansion of its pipeline with the addition of two products: pralsetinib and trilaciclib.

Pipeline metal tube forest
Olon is expanding its pipeline with two new products • Source: Ben Schonewille / Alamy Stock Photo

More from Strategy

More from Business